MIRA Pharmaceuticals, Inc. (MIRA) Earnings History
Annual and quarterly earnings data from 2020 to 2024
Loading earnings history...
MIRA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
MIRA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export MIRA earnings history in CSV or JSON format
Free sign-in required to download data
MIRA Pharmaceuticals, Inc. (MIRA) Earnings Overview
As of May 8, 2026, MIRA Pharmaceuticals, Inc. (MIRA) reported trailing twelve-month net income of -$28M, reflecting +21.5% year-over-year growth. The company earned $-1.47 per diluted share over the past four quarters.
Looking at the long-term picture, MIRA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$67,993 in fiscal 2020.
MIRA Pharmaceuticals, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ATAI (-$154M net income, -48464.0% margin), CMPS (-$288M net income), MNMD (-$238M net income), MIRA has comparable earnings metrics. Compare MIRA vs ATAI →
MIRA Earnings vs Peers
Earnings metrics vs comparable public companies
MIRA Historical Earnings Data (2020–2024)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$8M | +34.5% | -$8M | $-0.51 | - | - |
| 2023 | -$12M | -69.8% | -$9M | $-0.65 | - | - |
| 2022 | -$7M | -224.3% | -$7M | $-0.48 | - | - |
| 2021 | -$2M | -3101.1% | -$2M | $-0.15 | - | - |
| 2020 | $-67,993 | - | $-67,629 | $-0.00 | - | - |
See MIRA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MIRA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MIRA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMIRA — Frequently Asked Questions
Quick answers to the most common questions about buying MIRA stock.
Is MIRA growing earnings?
MIRA EPS is $-1.47, with earnings growth accelerating to +21.5%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-28M.
What are MIRA's profit margins?
MIRA Pharmaceuticals, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are MIRA's earnings?
MIRA earnings data spans 2020-2024. The accelerating earnings trend is +21.5% YoY. Historical data enables comparison across business cycles.